OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
3.800
-0.080 (-2.06%)
At close: Feb 21, 2025, 4:00 PM
3.830
+0.030 (0.79%)
After-hours: Feb 21, 2025, 7:56 PM EST
OraSure Technologies Market Cap
OraSure Technologies has a market cap or net worth of $283.46 million as of February 21, 2025. Its market cap has decreased by -48.77% in one year.
Market Cap
283.46M
Enterprise Value
15.99M
1-Year Change
-48.77%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since December 1, 1998, OraSure Technologies's market cap has increased from $72.90M to $283.46M, an increase of 288.83%. That is a compound annual growth rate of 5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 283.50M | 5.27% |
| Dec 31, 2024 | 269.30M | -55.31% |
| Dec 29, 2023 | 602.60M | 72.17% |
| Dec 30, 2022 | 350.00M | -44.09% |
| Dec 31, 2021 | 626.00M | -17.56% |
| Dec 31, 2020 | 759.30M | 53.18% |
| Dec 31, 2019 | 495.70M | -30.71% |
| Dec 31, 2018 | 715.40M | -37.45% |
| Dec 29, 2017 | 1.14B | 133.76% |
| Dec 30, 2016 | 489.30M | 34.53% |
| Dec 31, 2015 | 363.70M | -36.01% |
| Dec 31, 2014 | 568.40M | 62.54% |
| Dec 31, 2013 | 349.70M | -11.76% |
| Dec 31, 2012 | 396.30M | -7.88% |
| Dec 30, 2011 | 430.20M | 61.85% |
| Dec 31, 2010 | 265.80M | 13.93% |
| Dec 31, 2009 | 233.30M | 38.21% |
| Dec 31, 2008 | 168.80M | -59.27% |
| Dec 31, 2007 | 414.40M | 9.17% |
| Dec 29, 2006 | 379.60M | -5.45% |
| Dec 30, 2005 | 401.50M | 34.10% |
| Dec 31, 2004 | 299.40M | -14.36% |
| Dec 31, 2003 | 349.60M | 70.87% |
| Dec 31, 2002 | 204.60M | -54.74% |
| Dec 31, 2001 | 452.10M | 50.80% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.55B |
| UnitedHealth Group | 466.02B |
| Johnson & Johnson | 382.58B |
| Novo Nordisk | 370.06B |
| AbbVie | 351.33B |
| Abbott Laboratories | 229.36B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.80B |